Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupa Mazumder

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Current Cancer Drug Targets|April 3, 2024
Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive ReviewAbhijit Debnath, Rupa Mazumder
Natural Product Research|March 17, 2007
In vivo antitussive potentiality of Lagerstroemia parviflora flower extract using a cough model induced by sulfur dioxide in miceAvijit Mazumder, S Bhattacharya, Rupa Mazumder
Current Drug Targets|September 11, 2024
Revolutionizing Skin Cancer Treatment: The Rise of PD-1/PDL-1 and CTLA-4 as Key Therapeutic TargetsNeha Sharma, Rupa Mazumder, Pallavi Rai
Inflammopharmacology|February 12, 2026
Hydrogel-enabled drug delivery for ulcerative colitisMohit Sharma, Rupa Mazumder, Abhijit Debnath
Natural Product Research|April 29, 2006
Antimicrobial potentiality of Phyllanthus amarus against drug resistant pathogensAvijit Mazumder, Arun Mahato, Rupa Mazumder
Current Pharmaceutical Design|April 6, 2026
Advances in Liver Organoid Technology: A Paradigm Shift in Hepatic Research and TherapeuticsBhavani Pentela, Rupa Mazumder, Avijit Mazumder
Indian Journal of Experimental Biology|February 25, 2003
Antimicrobial potentiality of a phenothiazine group of antipsychotic drug-prochlorperazineRupa Mazumder, Sharmila Ray Chaudhuri, Avijit Mazumder
Current Pharmaceutical Design|September 5, 2025
Development of Novel Approaches for the Treatment of Cutaneous CandidiasisAbhay Kumar Singh, Rupa Mazumder, Anmol Dogra
Current Topics in Medicinal Chemistry|March 15, 2026
Target-Based Drug Delivery Approaches against Alzheimer's Disease - Recent UpdatesManu Sharma, Rupa Mazumder, Swarupanjali Padhi, et al.
Inflammopharmacology|October 9, 2025
URAT1 and GLUT9 as drug targets in gout: progress in transporter-directed therapies and delivery technologiesSoumya Mishra, Ranjit K Harwansh, Rupa Mazumder
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Current Cancer Drug Targets|April 3, 2024
Clinical Progress of Targeted Therapy for Breast Cancer: A Comprehensive ReviewAbhijit Debnath, Rupa Mazumder
Natural Product Research|March 17, 2007
In vivo antitussive potentiality of Lagerstroemia parviflora flower extract using a cough model induced by sulfur dioxide in miceAvijit Mazumder, S Bhattacharya, Rupa Mazumder
Current Drug Targets|September 11, 2024
Revolutionizing Skin Cancer Treatment: The Rise of PD-1/PDL-1 and CTLA-4 as Key Therapeutic TargetsNeha Sharma, Rupa Mazumder, Pallavi Rai
Inflammopharmacology|February 12, 2026
Hydrogel-enabled drug delivery for ulcerative colitisMohit Sharma, Rupa Mazumder, Abhijit Debnath
Natural Product Research|April 29, 2006
Antimicrobial potentiality of Phyllanthus amarus against drug resistant pathogensAvijit Mazumder, Arun Mahato, Rupa Mazumder
Current Pharmaceutical Design|April 6, 2026
Advances in Liver Organoid Technology: A Paradigm Shift in Hepatic Research and TherapeuticsBhavani Pentela, Rupa Mazumder, Avijit Mazumder
Indian Journal of Experimental Biology|February 25, 2003
Antimicrobial potentiality of a phenothiazine group of antipsychotic drug-prochlorperazineRupa Mazumder, Sharmila Ray Chaudhuri, Avijit Mazumder
Current Pharmaceutical Design|September 5, 2025
Development of Novel Approaches for the Treatment of Cutaneous CandidiasisAbhay Kumar Singh, Rupa Mazumder, Anmol Dogra
Current Topics in Medicinal Chemistry|March 15, 2026
Target-Based Drug Delivery Approaches against Alzheimer's Disease - Recent UpdatesManu Sharma, Rupa Mazumder, Swarupanjali Padhi, et al.
Inflammopharmacology|October 9, 2025
URAT1 and GLUT9 as drug targets in gout: progress in transporter-directed therapies and delivery technologiesSoumya Mishra, Ranjit K Harwansh, Rupa Mazumder
Pageof 7